An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 207188
Company: PRINSTON INC

Products on ANDA 207188

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
PAROXETINE MESYLATE	PAROXETINE MESYLATE	EQ 7.5MG BASE	CAPSULE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 207188

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
08/18/2017	ORIG-1	Approval		STANDARD	Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/207188Orig1s000ltr.pdf

Therapeutic Equivalents for ANDA 207188

PAROXETINE MESYLATE

CAPSULE;ORAL; EQ 7.5MG BASE
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BRISDELLE	PAROXETINE MESYLATE	EQ 7.5MG BASE	CAPSULE;ORAL	Prescription	Yes	AB	204516	LEGACY PHARMA
PAROXETINE MESYLATE	PAROXETINE MESYLATE	EQ 7.5MG BASE	CAPSULE;ORAL	Prescription	No	AB	207139	ACTAVIS LABS FL INC
PAROXETINE MESYLATE	PAROXETINE MESYLATE	EQ 7.5MG BASE	CAPSULE;ORAL	Prescription	No	AB	207188	PRINSTON INC

Top